NO952944L - Blandinger særlig for farmasöytisk anvendelse - Google Patents

Blandinger særlig for farmasöytisk anvendelse

Info

Publication number
NO952944L
NO952944L NO952944A NO952944A NO952944L NO 952944 L NO952944 L NO 952944L NO 952944 A NO952944 A NO 952944A NO 952944 A NO952944 A NO 952944A NO 952944 L NO952944 L NO 952944L
Authority
NO
Norway
Prior art keywords
pharmaceutical use
selective activity
specifically
exhibiting selective
mixtures especially
Prior art date
Application number
NO952944A
Other languages
English (en)
Other versions
NO952944D0 (no
Inventor
Serge Michel
Christine Cathelineau
Marie-Cecile Lenoir-Viale
Michel Demarchez
Original Assignee
Rech Dermatologiques Galderm C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rech Dermatologiques Galderm C filed Critical Rech Dermatologiques Galderm C
Publication of NO952944D0 publication Critical patent/NO952944D0/no
Publication of NO952944L publication Critical patent/NO952944L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Blandinger særlig for farmasøytisk anvendelse 'Oppfinnelsen vedrører anvendelse av nye kombinasjoner basert på minst en første ligand som utviser selektiv aktivitet for RXR reseptorer og minst en andre ligand som utviser selektiv aktivitet for RAR-a reseptoren, som aktive bestanddeler i, eller for fremstillingen av, farmasøytiske og/eller dermatolo- giske preparater som mer spesielt skal anvendes for å modulere proliferasjonen og/eller differensieringen av et HL-60 type cellesystem, og med det formål spesielt å behandle systemisk akutt promyelocytisk leukemi.
NO952944A 1994-07-27 1995-07-25 Blandinger særlig for farmasöytisk anvendelse NO952944L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9409307A FR2722985B1 (fr) 1994-07-27 1994-07-27 Nouvelles compositions a base d'un melange synergetique entre au moins un ligand specifique des rxrs et au moins un ligand specifique de rar-x ou de vdr, et leurs utilisations

Publications (2)

Publication Number Publication Date
NO952944D0 NO952944D0 (no) 1995-07-25
NO952944L true NO952944L (no) 1996-01-29

Family

ID=9465802

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952944A NO952944L (no) 1994-07-27 1995-07-25 Blandinger særlig for farmasöytisk anvendelse

Country Status (19)

Country Link
US (1) US5767148A (no)
EP (1) EP0694301B1 (no)
JP (1) JP2783521B2 (no)
KR (1) KR0168727B1 (no)
AT (1) ATE145134T1 (no)
AU (1) AU674479B2 (no)
BR (1) BR9502338A (no)
CA (1) CA2154730C (no)
DE (1) DE69500085T2 (no)
ES (1) ES2098164T3 (no)
FI (1) FI953567A7 (no)
FR (1) FR2722985B1 (no)
HU (1) HUT73793A (no)
IL (1) IL114765A (no)
NO (1) NO952944L (no)
NZ (1) NZ272527A (no)
PL (1) PL181061B1 (no)
RU (1) RU2120304C1 (no)
ZA (1) ZA955537B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2735370B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Procede pour identifier des composes agonistes des recepteurs rxrs
FR2735367B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Utilisation de ligands specifiques des recepteurs rxrs
FR2739777B1 (fr) * 1995-10-11 1997-11-14 Cird Galderma Ligand antagoniste rar-gamma ou agoniste rar-alpha en tant qu'inhibiteur d'apoptose
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
FR2753091B1 (fr) * 1996-09-09 2001-03-16 Oreal Utilisation d'un agoniste des recepteurs des retinoides de type rxr pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
WO1998046076A1 (en) * 1997-04-11 1998-10-22 Sidney Kimmel Cancer Center Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
AU733236B2 (en) * 1997-07-29 2001-05-10 Bristol-Myers Squibb Company Use of selective RXR agonists to prevent surgical adhesions
FR2779720B1 (fr) * 1998-06-12 2002-08-16 Galderma Rech Dermatologique Nouveaux composes diarylselenures et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie
US6436993B1 (en) * 1999-07-13 2002-08-20 The Salk Institute For Biological Studies Use of RAR antagonists as modulators of hormone mediated processes
US6904229B1 (en) * 1999-08-20 2005-06-07 Canon Kabushiki Kaisha Apparatus for recording signals on disk recording medium
DE60136477D1 (de) * 2000-10-02 2008-12-18 Hoffmann La Roche Retinoide zur behandlung von emphysem
RU2257204C2 (ru) * 2003-08-12 2005-07-27 Открытое Акционерное Общество "Фармакон" (ОАО "Фармакон") Противогрибковая гелевая фармацевтическая композиция и способ ее получения
CN100388532C (zh) * 2005-09-28 2008-05-14 浙江工业大学 一种锂二次电池的隔膜添加剂及锂二次电池隔膜

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3301328A1 (de) * 1982-02-01 1983-08-11 The Upjohn Co., 49001 Kalamazoo, Mich. Arzneimittel zur einleitenden bekaempfung von akuter oder chronischer, myelogener leukaemie
WO1993003713A1 (en) * 1991-08-23 1993-03-04 The Salk Institute For Biological Studies Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones
DE10199033I2 (de) * 1992-04-22 2003-01-09 Ligand Parmaceuticals Inc Retinoid-x Rezeptor selektive Verbindungen

Also Published As

Publication number Publication date
JPH0859511A (ja) 1996-03-05
IL114765A0 (en) 1995-11-27
NO952944D0 (no) 1995-07-25
US5767148A (en) 1998-06-16
ES2098164T3 (es) 1997-04-16
EP0694301A1 (fr) 1996-01-31
IL114765A (en) 2000-06-01
DE69500085D1 (de) 1996-12-19
CA2154730C (fr) 2000-02-15
ATE145134T1 (de) 1996-11-15
PL309772A1 (en) 1996-02-05
AU2327995A (en) 1996-02-08
BR9502338A (pt) 1996-02-27
ZA955537B (en) 1996-02-16
FI953567L (fi) 1996-01-28
JP2783521B2 (ja) 1998-08-06
RU2120304C1 (ru) 1998-10-20
FI953567A7 (fi) 1996-01-28
HU9502241D0 (en) 1995-09-28
EP0694301B1 (fr) 1996-11-13
PL181061B1 (pl) 2001-05-31
FI953567A0 (fi) 1995-07-26
DE69500085T2 (de) 1997-03-06
KR960003721A (ko) 1996-02-23
CA2154730A1 (fr) 1996-01-28
KR0168727B1 (ko) 1999-01-15
AU674479B2 (en) 1996-12-19
FR2722985B1 (fr) 1996-09-13
NZ272527A (en) 1997-01-29
FR2722985A1 (fr) 1996-02-02
HUT73793A (en) 1996-09-30

Similar Documents

Publication Publication Date Title
NO952944L (no) Blandinger særlig for farmasöytisk anvendelse
DE3784905D1 (de) Gamma-l-glutamyl-l-cysteinethylester und arzneimittel, die dieses als aktives mittel enthalten.
MXPA98007006A (es) Composiciones topicas que comprenden una emulsionde aceite en agua y un retinoide.
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
DK0781551T3 (da) Retinoid-formuleringer i porøse mikrosfærer til nedsat irritation og forbedret stabilitet
DE3485229D1 (de) Shampoo-praeparate.
MX9602973A (es) Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida.
JPS5427741A (en) Information processing organization
CA2015838A1 (en) Method of topically treating acne vulgaris
AU7895687A (en) Catechol derivatives, and preventive and remedial preparations for regressive disorders in the central nervous system containing the same
GB1500390A (en) Gelled aqueous solutions of vinyl ether/maleic anhydride copolymers their preparation and their application
FR2738745B1 (fr) Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide, et leurs utilisations
DE69619052D1 (de) Feste, wasserfreie, pharmazeutische Zubereitungen für vaginale Verwendung
ATE67667T1 (de) Neue topische metronidazol-formulierungen.
ATE52911T1 (de) Topische anwendung des 3-phenylacetylamino-2,6piperidindionszur behandlung von hautfalten und hyperpigmentierung.
JPS5218813A (en) Plasters for the relief of cutaneous diseases
DE3788195D1 (de) DIBENZ[b,e]OXEPINDERIVATE, SOWIE ARZNEIMITTEL, DIE DIESE ALS AKTIVE MITTEL ENTHALTEN.
GR3003539T3 (no)
IT1255076B (it) Microsfere biodegradabili ad uso farmaceutico e cosmetico
EP0352826A3 (en) Use of 5-aminosalicylic acid in the treatment of dermatological disorders
ES2141978T3 (es) Retinoides triciclicos, metodos para su produccion y uso.
ES8706027A1 (es) Procedimiento de obtencion de una composicion para el tratamiento de vitiligo
IE831030L (en) Benzopyrans and benzothiopyrans
ATE104554T1 (de) Topische praeparate.
IT8819650A0 (it) Apparecchio per la ginnastica attiva del viso e del collo.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application